Presenter: Joseph O’Donoghue, Ph.D. | Attending Physicist, Memorial Sloan-Kettering Cancer Center
Radiopharmaceutical therapies exploit the tumor targeting ability of small molecules, peptides, or antibodies to treat solid cancers with cytotoxic radiation while limiting damage to normal tissues.
During this webinar, the presenter will discuss:
- The complexities associated with radiopharmaceutical therapy development and translation into the clinic
- The controversial role of dosimetry in clinical radiopharmaceutical therapy
- The use of quantitative analysis to optimize radiopharmaceutical therapy